Human cell line-derived recombinant Factor VIII (Human-cl-rhFVIII)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human cell line-derived recombinant Factor VIII (Human-cl-rhFVIII), covering 2019-10-21 to 2019-10-21. Get the full timeline:
Most recent: Clinical Trial Update: Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients [Phase 3]